title: Differential inhibition of the human cell DNA replication complex-associated DNA polymerases by the antimetabolite 1-beta-D-arabinofuranosylcytosine triphosphate (ara-CTP).
abstract: The antimetabolite 1-beta-D-arabinofuranosylcytosine (ara-C) has been used as a highly effective agent for the treatment of leukemia. The active metabolite 1-beta-D-arabinofuranosylcytosine triphosphate (ara-CTP) is a potent inhibitor of DNA polymerases alpha, delta, and epsilon, and is responsible for inhibiting intact cell DNA synthesis. We have shown that a multiprotein complex, exhibiting many of the properties expected of the human cell DNA replication apparatus, can be readily isolated from human cells and tissues and is capable of supporting origin-dependent DNA synthesis in vitro. DNA polymerases alpha, delta, and epsilon are components of this multiprotein complex, termed the DNA synthesome, and we report here that the activities of these DNA synthesome-associated DNA polymerases are inhibited differentially by ara-CTP. Inhibition of the DNA synthesome-associated DNA polymerase alpha increased in a concentration-dependent manner, and was correlated closely with the inhibition of simian virus 40 (SV40) origin-dependent in vitro DNA replication, whereas DNA synthesome-associated DNA polymerase delta activity was not inhibited significantly by ara-CTP at 100 microM. Recent work has shown that the synthesome-associated DNA polymerase epsilon does not function in in vitro SV40 DNA replication, suggesting that only polymerases alpha and delta drive the DNA replication fork. Therefore, our results suggest that inhibition of the activity of the mammalian cell DNA synthesome by ara-CTP is due primarily to the inhibition of the DNA synthesome-associated DNA polymerase alpha. This observation implies that the drug may target specific phases of the DNA synthetic process in human cells.
authors.affiliation: Department of Pharmacology and Experimental Therapeutics, School of Medicine, University of Maryland, Baltimore, MD, USA.
authors.forename: S
authors.initials: S
authors.lastname: Han
authors.forename: R J
authors.initials: RJ
authors.lastname: Hickey
authors.forename: T D
authors.initials: TD
authors.lastname: Tom
authors.forename: P W
authors.initials: PW
authors.lastname: Wills
authors.forename: J E
authors.initials: JE
authors.lastname: Syväoja
authors.forename: L H
authors.initials: LH
authors.lastname: Malkas
mesh_terms: D001085:Arabinofuranosylcytosine Triphosphate / Q000494:pharmacology*; D002460:Cell Line; D004247:DNA / Q000096:biosynthesis / Q000187:drug effects; D004256:DNA Polymerase I / Q000037:antagonists & inhibitors* / Q000378:metabolism; D004258:DNA Polymerase III / Q000037:antagonists & inhibitors* / Q000378:metabolism; D004261:DNA Replication / Q000187:drug effects*; D006367:HeLa Cells; D006801:Humans; D019384:Nucleic Acid Synthesis Inhibitors / Q000494:pharmacology*; D013539:Simian virus 40 / Q000502:physiology
chemical_list: D019384:Nucleic Acid Synthesis Inhibitors; D001085:Arabinofuranosylcytosine Triphosphate; D004247:DNA; D004256:DNA Polymerase I; D004258:DNA Polymerase III